Financhill
Buy
66

MTL.TO Quote, Financials, Valuation and Earnings

Last price:
$15.35
Seasonality move :
1.16%
Day range:
$15.08 - $15.32
52-week range:
$11.81 - $16.06
Dividend yield:
5.5%
P/E ratio:
14.58x
P/S ratio:
0.67x
P/B ratio:
1.29x
Volume:
159.5K
Avg. volume:
180.1K
1-year change:
-1.86%
Market cap:
$1.3B
Revenue:
$2B
EPS (TTM):
$1.05

Earnings Data

Next earnings date for MTL.TO
Feb 12
2026
Most recent earnings per share
$0.34
Missed by $0.01
(Oct 22/2025)
Consensus Estimate
$0.36
(Oct 22/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

MTL.TO Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/12/2026 Q4 $544.7M -- -- $0.26 --
10/22/2025 Q3 $603.1M $561.7M $0.34 $0.36 -$0.01
07/24/2025 Q2 $523.5M $540.9M $0.29 $0.31 -$0.01
04/23/2025 Q1 $498.7M $497.1M $0.20 $0.22 -$0.02
02/13/2025 Q4 $518.8M $499M $0.21 $0.29 -$0.08
10/24/2024 Q3 $523.7M $532M $0.40 $0.36 $0.04
07/25/2024 Q2 $494.5M $495.6M $0.34 $0.29 $0.05
04/25/2024 Q1 $501.6M $462.6M $0.25 $0.30 -$0.06
02/15/2024 Q4 $499.6M $498.7M $0.32 $0.33 -$0.01
09/30/2023 Q3 $501.9M $503.9M $0.42 $0.35 $0.07
06/30/2023 Q2 -- $494.3M $0.39 -- --
03/31/2023 Q1 -- $497.8M $0.33 -- --
12/31/2022 Q4 -- $502.6M $0.62 -- --
09/30/2022 Q3 -- $518.4M $0.39 -- --
06/30/2022 Q2 -- $521.6M $0.43 -- --
03/31/2022 Q1 -- $456.9M $0.17 -- --
12/31/2021 Q4 -- $441.9M $0.21 -- --
09/30/2021 Q3 -- $432.5M $0.18 -- --
06/30/2021 Q2 -- $312.5M $0.23 -- --
03/31/2021 Q1 -- $290.5M $0.13 -- --
12/31/2020 Q4 -- $297.7M $0.10 -- --
09/30/2020 Q3 -- $290.9M $0.26 -- --
06/30/2020 Q2 -- $257.5M $0.22 -- --
03/31/2020 Q1 -- $318.2M $0.04 -- --
12/31/2019 Q4 -- $314.6M $0.08 -- --
09/30/2019 Q3 -- $325.3M $0.20 -- --
06/30/2019 Q2 -- $319M $0.30 -- --
03/31/2019 Q1 -- $319.6M $0.11 -- --
02/08/2019 Q4 -- $333.3M -$0.77 -- --
09/30/2018 Q3 -- $339.7M $0.21 -- --
06/30/2018 Q2 -- $295.7M $0.13 -- --
03/31/2018 Q1 -- $292.1M $0.01 -- --
02/07/2018 Q4 -- $296.1M $0.05 -- --
09/30/2017 Q3 -- $283.9M $0.25 -- --
06/30/2017 Q2 -- $273.7M $0.19 -- --
03/31/2017 Q1 -- $284.9M $0.14 -- --
12/31/2016 Q4 -- $257.7M -$0.01 -- --
09/30/2016 Q3 -- $258.7M $0.17 -- --
06/30/2016 Q2 -- $246.9M $0.14 -- --
03/31/2016 Q1 -- $271.7M $0.23 -- --
12/31/2015 Q4 -- $287.7M $0.03 -- --

Mullen Group Ltd. Earnings Questions

  • How Much did Mullen Group Ltd. Generate in Revenue Last Quarter?

    Mullen Group Ltd. reported $561.7M worth of top line sales in its most recent quarter.

  • Did Mullen Group Ltd. Beat Earnings Last Quarter?

    Mullen Group Ltd. announced earnings per share of $0.34 which represents a miss of analyst forecast a $0.36 per share.

  • Is Mullen Group Ltd. Profitable?

    Mullen Group Ltd. reported $138.5M that represents $1.43 per share over the last quarter.

  • What is the Analyst Consensus for Mullen Group Ltd. EPS Next Year?

    Mullen Group Ltd.'s earnings are forecast to decrease from $1.23 per share to $1.28 per share next year representing a decrease of -14.65%.

  • When is Mullen Group Ltd.'s Earnings Date?

    Mullen Group Ltd.'s next earnings date is February 12, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did Netflix Buy Warner Bros?
Why Did Netflix Buy Warner Bros?

Following a bidding war, Netflix (NASDAQ:NFLX) has announced its intention…

Why Did SoFi Stock Drop?
Why Did SoFi Stock Drop?

Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…

Will Robinhood Win AI Investing?
Will Robinhood Win AI Investing?

Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…

Stock Ideas

Buy
54
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
56
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
59
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
67
GPCR alert for Dec 9

Structure Therapeutics, Inc. [GPCR] is down 4.73% over the past day.

Buy
62
SMX alert for Dec 9

SMX (Security Matters) Plc [SMX] is up 7.57% over the past day.

Buy
90
KYMR alert for Dec 9

Kymera Therapeutics, Inc. [KYMR] is down 7.87% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock